Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/assessment-of-infectious-risk-in-clinical-xenotransplantation-the-O0zJMfRqz6
References (39)
-
( Heneine W , Tibell A , Switzer WM et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet‐cell xenografts. Lancet 1998; 352: 695–699.9728986)
Heneine W , Tibell A , Switzer WM et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet‐cell xenografts. Lancet 1998; 352: 695–699.9728986Heneine W , Tibell A , Switzer WM et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet‐cell xenografts. Lancet 1998; 352: 695–699.9728986, Heneine W , Tibell A , Switzer WM et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet‐cell xenografts. Lancet 1998; 352: 695–699.9728986
-
( Fishman JA , Greenwald MA , Grossi PA . Transmission of infection with human allografts: essential considerations in donor screening. Clin Infect Dis 2012; 55: 720–727.22670038)
Fishman JA , Greenwald MA , Grossi PA . Transmission of infection with human allografts: essential considerations in donor screening. Clin Infect Dis 2012; 55: 720–727.22670038Fishman JA , Greenwald MA , Grossi PA . Transmission of infection with human allografts: essential considerations in donor screening. Clin Infect Dis 2012; 55: 720–727.22670038, Fishman JA , Greenwald MA , Grossi PA . Transmission of infection with human allografts: essential considerations in donor screening. Clin Infect Dis 2012; 55: 720–727.22670038
-
G. Pugliese, M. Favero (2001)
PHS Guideline on Infectious Disease Issues in XenotransplantationInfection Control & Hospital Epidemiology, 22
-
J. Fishman, M. Greenwald, P. Grossi (2012)
Transmission of infection with human allografts: essential considerations in donor screening.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 55 5
-
W. Heneine, A. Tibell, W. Switzer, P. Sandstrom, G. Rosales, Aprille Mathews, O. Korsgren, L. Chapman, T. Folks, C. Groth (1998)
No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenograftsThe Lancet, 352
-
(1997)
OECD / WHO Consultation on Xenotransplantation Surveillance – WHO / CDS / CSR / EPH / 2001 . 2 ( Guidance Document ) 2000 -
( Wood JC , Quinn G , Suling KM et al. Identification of exogenous forms of human‐tropic porcine endogenous retrovirus in miniature Swine. J Virol 2004; 78: 2494–2501.14963150)
Wood JC , Quinn G , Suling KM et al. Identification of exogenous forms of human‐tropic porcine endogenous retrovirus in miniature Swine. J Virol 2004; 78: 2494–2501.14963150Wood JC , Quinn G , Suling KM et al. Identification of exogenous forms of human‐tropic porcine endogenous retrovirus in miniature Swine. J Virol 2004; 78: 2494–2501.14963150, Wood JC , Quinn G , Suling KM et al. Identification of exogenous forms of human‐tropic porcine endogenous retrovirus in miniature Swine. J Virol 2004; 78: 2494–2501.14963150
-
Y. Takeuchi, C. Patience, S. Magre, Robin Weiss, Papia Banerjee, P. LeTissier, J. Stoye (1999)
Host range and interference studies of three classes of pig endogenous retrovirus.Journal of virology, 72 12
-
S. Wynyard, D. Nathu, O. Garkavenko, J. Denner, R. Elliott (2014)
Microbiological safety of the first clinical pig islet xenotransplantation trial in New ZealandXenotransplantation, 21
-
( First World Health Organization Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials: Changsha, China, 19–21 November 2008. The Changsha Communique. Xenotransplantation 2008; 16: 61–63.)
First World Health Organization Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials: Changsha, China, 19–21 November 2008. The Changsha Communique. Xenotransplantation 2008; 16: 61–63.First World Health Organization Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials: Changsha, China, 19–21 November 2008. The Changsha Communique. Xenotransplantation 2008; 16: 61–63., First World Health Organization Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials: Changsha, China, 19–21 November 2008. The Changsha Communique. Xenotransplantation 2008; 16: 61–63.
-
( Takeuchi Y , Patience C , Magre S et al. Host range and interference studies of three classes of pig endogenous retrovirus. J Virol 1998; 72: 9986–9991.9811736)
Takeuchi Y , Patience C , Magre S et al. Host range and interference studies of three classes of pig endogenous retrovirus. J Virol 1998; 72: 9986–9991.9811736Takeuchi Y , Patience C , Magre S et al. Host range and interference studies of three classes of pig endogenous retrovirus. J Virol 1998; 72: 9986–9991.9811736, Takeuchi Y , Patience C , Magre S et al. Host range and interference studies of three classes of pig endogenous retrovirus. J Virol 1998; 72: 9986–9991.9811736
-
J. Fishman (2007)
Infection in solid-organ transplant recipients.The New England journal of medicine, 357 25
-
QUINN G, SULING KM et al -
James Wood, G. Quinn, K. Suling, B. Oldmixon, B. Tine, R. Cina, S. Arn, Christine Huang, L. Scobie, D. Onions, D. Sachs, H. Schuurman, J. Fishman, C. Patience (2004)
Identification of Exogenous Forms of Human-Tropic Porcine Endogenous Retrovirus in Miniature SwineJournal of Virology, 78
-
( Patience C , Patton GS , Takeuchi Y et al. No evidence of pig DNA or retroviral infection in patients with short‐term extracorporeal connection to pig kidneys. Lancet 1998; 352: 699–701.9728987)
Patience C , Patton GS , Takeuchi Y et al. No evidence of pig DNA or retroviral infection in patients with short‐term extracorporeal connection to pig kidneys. Lancet 1998; 352: 699–701.9728987Patience C , Patton GS , Takeuchi Y et al. No evidence of pig DNA or retroviral infection in patients with short‐term extracorporeal connection to pig kidneys. Lancet 1998; 352: 699–701.9728987, Patience C , Patton GS , Takeuchi Y et al. No evidence of pig DNA or retroviral infection in patients with short‐term extracorporeal connection to pig kidneys. Lancet 1998; 352: 699–701.9728987
-
(2012)
SCOBIE L, TAKEUCHI Y -
D. Akiyoshi, M. Denaro, Haihong Zhu, J. Greenstein, P. Banerjee, J. Fishman (1998)
Identification of a Full-Length cDNA for an Endogenous Retrovirus of Miniature SwineJournal of Virology, 72
-
( World Health Organization . OECD/WHO Consultation on Xenotransplantation Surveillance – WHO/CDS/CSR/EPH/2001.2 (Guidance Document) 2000. http://www.who.int/transplantation/publications/OECD_WHO.pdf. )
World Health Organization . OECD/WHO Consultation on Xenotransplantation Surveillance – WHO/CDS/CSR/EPH/2001.2 (Guidance Document) 2000. http://www.who.int/transplantation/publications/OECD_WHO.pdf.World Health Organization . OECD/WHO Consultation on Xenotransplantation Surveillance – WHO/CDS/CSR/EPH/2001.2 (Guidance Document) 2000. http://www.who.int/transplantation/publications/OECD_WHO.pdf. , World Health Organization . OECD/WHO Consultation on Xenotransplantation Surveillance – WHO/CDS/CSR/EPH/2001.2 (Guidance Document) 2000. http://www.who.int/transplantation/publications/OECD_WHO.pdf.
-
( Garkavenko O , Croxson MC , Irgang M et al. Monitoring for presence of potentially xenotic viruses in recipients of pig islet xenotransplantation. J Clin Microbiol 2004; 42: 5353–5356.15528741)
Garkavenko O , Croxson MC , Irgang M et al. Monitoring for presence of potentially xenotic viruses in recipients of pig islet xenotransplantation. J Clin Microbiol 2004; 42: 5353–5356.15528741Garkavenko O , Croxson MC , Irgang M et al. Monitoring for presence of potentially xenotic viruses in recipients of pig islet xenotransplantation. J Clin Microbiol 2004; 42: 5353–5356.15528741, Garkavenko O , Croxson MC , Irgang M et al. Monitoring for presence of potentially xenotic viruses in recipients of pig islet xenotransplantation. J Clin Microbiol 2004; 42: 5353–5356.15528741
-
K. Paradis, G. Langford, Z. Long, W. Heneine, P. Sandstrom, W. Switzer, L. Chapman, Christine Lockey, D. Onions, E. Otto (1999)
Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group.Science, 285 5431
-
(2003)
Guidance for Industry: Source Animal, Product, Preclinical, and Clinical Issues Concerning the Use of Xenotransplantation Products in Humans -
G. Mattiuzzo, L. Scobie, Y. Takeuchi (2008)
Strategies to enhance the safety profile of xenotransplantation: minimizing the risk of viral zoonosesCurrent Opinion in Organ Transplantation, 13
-
( Akiyoshi DE , Denaro M , Zhu H et al. Identification of a full‐length cDNA for an endogenous retrovirus of miniature swine. J Virol 1998; 72: 4503–4507.9557749)
Akiyoshi DE , Denaro M , Zhu H et al. Identification of a full‐length cDNA for an endogenous retrovirus of miniature swine. J Virol 1998; 72: 4503–4507.9557749Akiyoshi DE , Denaro M , Zhu H et al. Identification of a full‐length cDNA for an endogenous retrovirus of miniature swine. J Virol 1998; 72: 4503–4507.9557749, Akiyoshi DE , Denaro M , Zhu H et al. Identification of a full‐length cDNA for an endogenous retrovirus of miniature swine. J Virol 1998; 72: 4503–4507.9557749
-
J. Fishman (1998)
Infection and Xenotransplantation: Developing Strategies to Minimize RiskAnnals of the New York Academy of Sciences, 862
-
( Mattiuzzo G , Scobie L , Takeuchi Y . Strategies to enhance the safety profile of xenotransplantation: minimizing the risk of viral zoonoses. Curr Opin Organ Transplant 2008; 13: 184–188.18685301)
Mattiuzzo G , Scobie L , Takeuchi Y . Strategies to enhance the safety profile of xenotransplantation: minimizing the risk of viral zoonoses. Curr Opin Organ Transplant 2008; 13: 184–188.18685301Mattiuzzo G , Scobie L , Takeuchi Y . Strategies to enhance the safety profile of xenotransplantation: minimizing the risk of viral zoonoses. Curr Opin Organ Transplant 2008; 13: 184–188.18685301, Mattiuzzo G , Scobie L , Takeuchi Y . Strategies to enhance the safety profile of xenotransplantation: minimizing the risk of viral zoonoses. Curr Opin Organ Transplant 2008; 13: 184–188.18685301
-
O. Garkavenko, M. Croxson, M. Irgang, Alexander Karlas, J. Denner, Robert Elliott (2004)
Monitoring for Presence of Potentially Xenotic Viruses in Recipients of Pig Islet XenotransplantationJournal of Clinical Microbiology, 42
-
(1998)
DENARO M, ZHU H et al -
First World Health Organization Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials -
Takeuchi (1998)
Host range and interference studies of three classes of pig endogenous retrovirusJ Virol, 72
-
J. Fishman, L. Scobie, Y. Takeuchi (2012)
Xenotransplantation‐associated infectious risk: a WHO consultationXenotransplantation, 19
-
C. Patience, G. Patton, Y. Takeuchi, R. Weiss, M. Mcclure, L. Rydberg, M. Breimer (1998)
No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneysThe Lancet, 352
-
( Paradis K , Langford G , Long Z et al. Search for cross‐species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 1999; 285: 1236–1241.10455044)
Paradis K , Langford G , Long Z et al. Search for cross‐species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 1999; 285: 1236–1241.10455044Paradis K , Langford G , Long Z et al. Search for cross‐species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 1999; 285: 1236–1241.10455044, Paradis K , Langford G , Long Z et al. Search for cross‐species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 1999; 285: 1236–1241.10455044
-
(2003)
and Drug Administration -
(1998)
and xenotransplantation -
First World Health Organization Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials: Changsha, China, 19-21 November 2008. The Changsha Communique
Xenotransplantation, 16
-
( Wynyard S , Nathu N , Garkavenko O et al. Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand. Xenotransplantation 2014; 21: 309–323.24801820)
Wynyard S , Nathu N , Garkavenko O et al. Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand. Xenotransplantation 2014; 21: 309–323.24801820Wynyard S , Nathu N , Garkavenko O et al. Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand. Xenotransplantation 2014; 21: 309–323.24801820, Wynyard S , Nathu N , Garkavenko O et al. Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand. Xenotransplantation 2014; 21: 309–323.24801820
-
J. Fishman, C. Patience (2004)
Xenotransplantation: Infectious Risk RevisitedAmerican Journal of Transplantation, 4
-
(1997)
World Health Organization. WHO consultation on xenotransplantation -WHO/EMC/ZOO/98.1 (Guidance Document) -
( U.S. Food and Drug Administration . Guidance for Industry: Source Animal, Product, Preclinical, and Clinical Issues Concerning the Use of Xenotransplantation Products in Humans, 2003.)
U.S. Food and Drug Administration . Guidance for Industry: Source Animal, Product, Preclinical, and Clinical Issues Concerning the Use of Xenotransplantation Products in Humans, 2003.U.S. Food and Drug Administration . Guidance for Industry: Source Animal, Product, Preclinical, and Clinical Issues Concerning the Use of Xenotransplantation Products in Humans, 2003., U.S. Food and Drug Administration . Guidance for Industry: Source Animal, Product, Preclinical, and Clinical Issues Concerning the Use of Xenotransplantation Products in Humans, 2003.
- Publisher
- Wiley
- Copyright
- © 2014 John Wiley & Sons A/S
- ISSN
- 0908-665X
- eISSN
- 1399-3089
- DOI
- 10.1111/xen.12118
- pmid
- 25098837
- Publisher site
- See Article on Publisher Site
Abstract
Xenotransplantation 2014: 21: 307–308 © 2014 John Wiley & Sons A/S doi: 10.1111/xen.12118 Published by John Wiley & Sons Ltd. XENOTRANSPLANTATION Editorial Assessment of infectious risk in clinical xenotransplantation: The lessons for clinical allotransplantation The infectious risk of clinical xenotransplantation donor animals and human recipients of porcine is unknown. Based on experience with human xenografts to prevent infectious transmission events [13]. allotransplantation, it has been assumed that the potential exists for the transmission of infection Despite this impressive progress, the actual risk with the viable cells or tissues of a xenograft [1–4]. of disease transmission in xenotransplantation This risk was amplified by concerns regarding the remains unknown. Early clinical data from a per- unique potential risk of the transmission of zoo- iod prior to optimal assay development suggested notic infectious agents of animal (swine) origin that transmission events were uncommon and into human recipients for which diagnostic tools might be unrecognizable among the expected infec- did not exist and the behavior of which was tions occurring in immunocompromised transplant unpredictable in the immunosuppressed human recipients [14–17]. However, significant progress graft recipient. The terms “xenosis,” “direct zoo- has been made in the microbiology of xenotrans- nosis,” and “xenozoonosis” were used
Journal
Xenotransplantation – Wiley
Published: Jan 1, 2014